CNS Pharmaceuticals, Inc. (CNSP) insider buying and selling

NASDAQ: CNSP · Source: SEC Form 4 filings · Latest trade reported

There were no open-market insider purchases or sales at CNS Pharmaceuticals, Inc. (CNSP) in the last 90 days. Over the last 12 months, 2 insiders bought $44K of the stock, led by Faith L. Charles (Director), who bought $34K on May 18, 2026.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
0
$0 · 0 insiders
Insider buys, 12 months
2
$44K · 2 insiders
Insider sales, 12 months
0
$0 · 0 insiders

This is the public summary. Create a free account to see CNSP’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock CNSP

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at CNS Pharmaceuticals, Inc.
DateInsiderTypeSharesPriceValue
Faith L. Charles
Director
Open market purchase7,100$4.79$34K
Michal Fisher
CTO
Open market purchase2,000$5.00$10K

What the CNSP insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for CNS Pharmaceuticals, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with CNSP Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about CNSP insider trading

Who bought CNS Pharmaceuticals, Inc. (CNSP) stock recently?

Insiders who bought CNS Pharmaceuticals, Inc. stock on the open market in the last 12 months: Faith L. Charles ($34K), Michal Fisher ($10K). The most recent purchase was reported on May 18, 2026.

Are insiders buying or selling CNSP?

Over the last 12 months insiders were net buyers of CNSP on discretionary trades: $44K bought against $0 sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see CNSP in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.